-+ 0.00%
-+ 0.00%
-+ 0.00%

Lexaria signs material transfer agreement with PegBio to test DehydraTECH with GLP-1 molecule

PUBT·08/13/2026 13:00:53
Listen to the news
Lexaria signs material transfer agreement with PegBio to test DehydraTECH with GLP-1 molecule
  • Lexaria entered a material transfer agreement with PegBio to test DehydraTECH with PegBio’s proprietary GLP-1 molecule.
  • PegBio will supply the molecule for DehydraTECH processing, followed by animal pharmacokinetic studies to assess performance.
  • Results could inform follow-on business decisions, including potential technology licensing or other commercial arrangements.
  • PegBio’s lead GLP-1 product won China approval in November 2025 as an injectable treatment.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lexaria Bioscience Corp. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202608130900ACCESSWRNAPR_____1206856) on August 13, 2026, and is solely responsible for the information contained therein.